MedPath

A Trial of Skin Care Protocols for Facial Resurfacing

Phase 4
Completed
Conditions
Facial Photo Damage
Periocular Fine Wrinkles
Perioral Fine Wrinkles
Registration Number
NCT01113606
Lead Sponsor
The Plastic Surgery Foundation
Brief Summary

The aims of the Skin Product Assessment Research study were to (1) develop an infrastructure and process for industry-sponsored, Plastic Surgery Educational Foundation (PSEF) research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System (ODNS) and conventional therapy as treatment adjuncts in ablative facial resurfacing.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • patients with moderate to severe photo damage and rhytids, undergoing full or partial face resurfacing with chemical peel or ablative laser.
  • Fitzpatrick I-IV skin types
Exclusion Criteria
  • patients unable to complete the regimen or who had used topical prescription steroids, retinoids, depigmentation products or other products containing hydroquinone and polyhydroxy acids within 8 weeks of enrollment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (8)

Suite 135

🇺🇸

Oxnard, California, United States

Suite 175

🇺🇸

Rancho Santa Margarita, California, United States

Aesthetic and Plastic Surgery Institute

🇺🇸

Greeley, Colorado, United States

Brevard Plastic Surgery and Skin Institute

🇺🇸

Melbourne, Florida, United States

Kentucky Aesthetic and Plastic Surgery Institute

🇺🇸

Louisville, Kentucky, United States

Center for Plastic and Reconstructive Surgery

🇺🇸

Ypsilanti, Michigan, United States

Body Aesthetic Plastic Surgery

🇺🇸

St. Louis, Missouri, United States

Advanced Cosmetis Surgery

🇺🇸

Greenville, South Carolina, United States

Suite 135
🇺🇸Oxnard, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.